Liu and colleagues used NK cells from the cord blood (CB) for incorporation of genes for CAR-CD19, IL-15 cytokine and caspase 9 as safety switch (iC9/CAR.19/IL15) to efficiently kill CD19-positive leukemia/lymphoma cells lines (156, 163). Here, CD19 is linked to lymphoma.